首页> 外国专利> DEVELOPMENT OF METHOD FOR SCREENING OF COMPOUND CAPABLE OF IMPROVING THE PRODUCTION OF REGULATORY T CELL, AND METHOD FOR PRODUCTION OF REGULATORY T CELL USING IMMUNOSUPPRESSIVE MACROLIDE ANTIBIOTIC

DEVELOPMENT OF METHOD FOR SCREENING OF COMPOUND CAPABLE OF IMPROVING THE PRODUCTION OF REGULATORY T CELL, AND METHOD FOR PRODUCTION OF REGULATORY T CELL USING IMMUNOSUPPRESSIVE MACROLIDE ANTIBIOTIC

机译:筛选可提高调节性T细胞产量的复合物的方法的开发,以及使用免疫抑制性大环内酯类抗生素生产调节性T细胞的方法

摘要

The present invention provides a screening method for a compound capable of inducing regulatory T cells, comprising the following steps: (1) a step for culturing CD4 + T cells having a naive phenotype in the presence of a test compound, and isolating T cells from the culture product; (2) a step for evaluating the immunosuppressive function of the T cells isolated in the step (1); (3) a step for obtaining the foregoing test compound as a compound capable of inducing regulatory T cells if the results of the evaluation in the step (2) show that the T cells isolated in the step (1) have immunosuppressive function. The present invention also provides a method of producing regulatory T cells, comprising culturing CD4 + T cells having a naive phenotype in the presence of a rapamycin compound to obtain regulatory T cells. The regulatory T cell produced by the method can be used as an immunomodulator for the prophylaxis or treatment of the rejection in organ transplantation, an allergic disease, an autoimmune disease, a graft-versus-host disease (GVHD), infertility and the like.
机译:本发明提供了一种能够诱导调节性T细胞的化合物的筛选方法,包括以下步骤:(1)在受试化合物的存在下培养具有幼稚表型的CD4 + T细胞,并从培养产物中分离T细胞的步骤;(2)评价步骤(1)中分离出的T细胞的免疫抑制功能的步骤。(3)如果步骤(2)中的评估结果表明步骤(1)中分离的T细胞具有免疫抑制功能,则获得上述待测化合物作为能够诱导调节性T细胞的化合物的步骤。本发明还提供了产生调节性T细胞的方法,包括在雷帕霉素化合物的存在下培养具有幼稚表型的CD4 + T细胞以获得调节性T细胞。通过该方法产生的调节性T细胞可以用作免疫调节剂,用于预防或治疗器官移植中的排斥,变态反应性疾病,自身免疫性疾病,移植物抗宿主病(GVHD),不育症等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号